Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Tweedy, Browne Value Fund Investment Committee | “Ionis was a top-performing position across all funds following encouraging Phase 3 clinical trial data. The results validated its antisense technology platform and pipeline potential, prompting renewed investor optimism. BSD Analysis: Ionis's platform success in late-stage trials highlights its potential as a long-duration biotech compounder. Its robust pipeline diversification across neurological and cardiometabolic diseases mitigates binary risk. With partnerships with major pharma companies, Ionis combines scientific depth with financial prudence, offering high asymmetric upside.” | BULL | Q3 2025 Oct 1, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
